ReviewJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2026
Advances in artificial intelligence for neuroimaging.
Review in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Most neuroimaging applications involve a multi-step pipeline encompassing image acquisition, reconstruction, enhancement, registration, segmentation, diagnosis, and prognosis. These steps are fundamental for diagnosing neurological disorders, tracking disease progression, and guiding treatment. Recent advances in artificial intelligence (AI), particularly deep learning, are transforming each stage by improving efficiency, image quality and resolution, accuracy, and clinical utility. This review surveys recent advances and emerging trends across diverse neuroimaging modalities, including multimodal studies that integrate imaging with clinical and molecular data. New AI approaches address long-standing challenges in neuroimaging: physics-informed models incorporate prior knowledge to improve reconstruction, self-supervised learning mitigates the lack of ground-truth data in incomplete datasets, graph neural networks capture the non-Euclidean nature of connectomics, generative diffusion models predict missing contrasts and enable cross modal synthesis, and data harmonization techniques reduce scanner and site variability to improve generalizability. Despite these advances, key barriers such as heterogeneous and biased datasets, limited benchmarking, and regulatory challenges impede the translation of these methods into clinical workflows. We conclude by highlighting priorities for developing reliable, generalizable, and interpretable that can advance both neuroimaging research and real-world patient care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.